1. Home
  2. BETR vs CTKB Comparison

BETR vs CTKB Comparison

Compare BETR & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Better Home & Finance Holding Company

BETR

Better Home & Finance Holding Company

HOLD

Current Price

$25.22

Market Cap

538.7M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.12

Market Cap

541.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BETR
CTKB
Founded
2014
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.7M
541.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BETR
CTKB
Price
$25.22
$4.12
Analyst Decision
Buy
Hold
Analyst Count
1
4
Target Price
$40.00
$5.63
AVG Volume (30 Days)
365.3K
1.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$55.02
$5.42
Revenue Next Year
$65.66
$7.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
17.67
52 Week Low
$11.90
$2.94
52 Week High
$94.06
$6.18

Technical Indicators

Market Signals
Indicator
BETR
CTKB
Relative Strength Index (RSI) 37.92 49.53
Support Level $24.91 $3.30
Resistance Level $29.98 $4.29
Average True Range (ATR) 2.11 0.24
MACD 0.16 0.04
Stochastic Oscillator 19.97 65.05

Price Performance

Historical Comparison
BETR
CTKB

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Share on Social Networks: